Aptose Biosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APTO and other ETFs, options, and stocks.

About APTO

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. 

CEO
William G. Rice
CEOWilliam G. Rice
Employees
42
Employees42
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
1986
Founded1986
Employees
42
Employees42

APTO Key Statistics

Market cap
55.33M
Market cap55.33M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
237.83K
Average volume237.83K
High today
$0.6181
High today$0.6181
Low today
$0.58
Low today$0.58
Open price
$0.6181
Open price$0.6181
Volume
247.74K
Volume247.74K
52 Week high
$2.78
52 Week high$2.78
52 Week low
$0.58
52 Week low$0.58

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

APTO Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.